BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS FOR USE IN DECREASING ABDOMINAL PAIN IN A POSTMENOPAUSAL WOMAN

USPTO Patent Application US 2017/0196916 A1
Application Date: Jul. 13rd, 2017

ABSTRACT

The present invention is based upon the findings of two large clinical studies to determine the efficacy of daily consumption of the probiotic strain Bifidobacterium animalis subsp. lactis deposited as...
Assignee(s):
Application Number:
15/327,193
International Classification:
A61K 35/745 (20060101); A23L 2/52 (20060101); A23L 33/00 (20060101); A23L 33/135 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1-15. (canceled)

DESCRIPTION

FIELD OF THE INVENTION

The present invention is based upon the findings of two large clinical studies to determine the efficacy of daily consumption of the probiotic strain Bifidobacterium animalis subsp. lactis deposited as DSM 15954 for 4 weeks on abdominal pain in healthy women with abdominal discomfort and a low defecation frequency.
Back to Top